L. Flohe, J. R. Andreesen, R. Brigelius-Flohe, et al., Selenium, the element of the Moon, in life on earth, Life
49, 411–420 (2000).
J. Köhrle, R. Brigelius-Flohe, A. Böck, et al., Selenium in biology: facts and medical perspectives, Biol. Chem.
381, 849–864 (2000).
K. Overvad, Selenium and cancer, in Role of Trace Elements for Health Promotion and Disease Prevention, B. Sandström and P. Walter, eds., Bibl. Nutr. Dieta. Vol. 54, Karger, Basel, pp. 141–149 (1998).
M. P. Rayman, The importance of selenium to human health, Lancet
356, 233–241 (2000).
M. Sanz Alaejos, F. Diaz Romero, and C. Diaz Romero, Selenium and cancer: some nutritional aspects, Nutrition
16, 376–383 (2000).
M. Vinceti, S. Rovest, M. Bergomi, et al., The epidemiology of selenium and human cancer, Tumori
86, 105–118 (2000).
P. J. Aggett and A. Favier, Zinc, Int. J. Vitam. Nutr. Res.
63(4), 301–307 (1993).
J. Arnaud, Copper, Int. J. Vitam. Nutr. Res.
63(4), 308–311 (1993).
J. van Dael and H. Deestro, Selenium, Int. J. Vitam. Nutr. Res.
63(4), 312–316 (1993).
A. M. Viegas-Crespo, M. L. Pavão, O. Paulo, et al., Trace element status (Se, Cu, Zn) and serum lipid profile in Portuguese subjects of San Miguel Island from Azores’ archipelago, J. Trace Elements Med. Biol.
14, 1–5 (2000).
I. Yücel, F. Arpaci, A. Özet, et al., Serum copper and zinc levels and copper/zinc ration in patients with breast cancer, Biol. Trace Element Res.
40, 31–38 (1994).
C. Köksoy, G. O. Kavas, E. Akcil, et al., Trace elements and superoxide dismutase in benign and malignant breast disease, Breast Cancer Res. Treat.
45, 1–4 (1997).
J. Köhrle, Thyroid hormone deiodinase—a selenoenzyme family acting as gate keepers to thyroid hormone action, Acta Med. Austr.
23, 17–30 (1996).
J. Köhrle, Thyroid hormone deiodination in target tissue—a regulatory role for the trace element, Exp. Clin. Endocrinol.
102, 63–89 (1994).
A. Kralik, K. Eder, and M. Kirchgessner, Influence of zinc and selenium deficiency on parameters relation to thyroid hormone metabolism, Horm. Metab. Res.
28, 223–226 (1996).
M. J. Berry and P. R. Larsen, The role of selenium in thyroid hormone action, Endocr. Rev.
132, 207–219 (1992).
J. Köhrle, M. Oertel, and M. Gross, Selenium supply regulates thyroid function, thyroid hormone synthesis and metabolism by altering the expression of the selenoenzymes type I 5′-deiodinase and glutathione peroxidase, Thyroidol. Clin. Exp.
4, 17–21 (1992).
M. D. Chen, Y. M. Song, C. T. Tsou, et al., Leptin concentration and the Zn/Cu ration in plasma in women with thyroid disorder, Biol. Trace Element Res.
75, 99–105 (2000).
P. Wobrauschek, Trends, applications and results in x-ray fluorescence analysis, J. Radiat. Nucl. Chem.
167, 433–444 (1993).
U. Majewska, J. Braziewicz, D. Banaś, et al., An elemental correlation study in cancerous breast tissue by total reflection x-ray fluorescence, Biol. Trace Element Res.
60, 91–100 (1997).
U. Majewska, J. Braziewicz, D. Banaś, et al., Some aspects of statistical distribution of trace element concentrations in biomedical samples, Nucl. Instrum. Methods Phys. Res. B
150, 254–259 (1999).
A. Kubala-Kukuś, J. Braziewicz, U. Majewska, et al., Influence of detection limit on the measured concentration distribution of trace elements. X-Ray Spectrom.
30, 348–352 (2001).
A. N. Garg, V. Singh, R. G. Weginwar, et al., An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis, Biol. Trace Element Res.
46, 185–201 (1994).
K. H. Ng, D. A. Bradley, L. M. Looi, et al., Differentiation of elemental composition of normal and malignant breast tissue by instrumental neutron activation analysis, Appl. Radiat. Isot.
44, 511–516 (1993).
M. Gerber, S. Richardson, R. Salkeld, et al., Antioxidants in female breast cancer patients, Cancer Invest.
91, 421–428 (1991).
F. Cavallo, M. Gerber, and E. Marrubini, Zinc and copper in breast cancer, Cancer
67, 738–745 (1991).
A. Zoboli, A case-control study on selenium, zinc and copper in plasma and hair of subjects affected by breast and lung cancer, Biol. Trace Element Res.
51, 23–30 (1996).
W. Buchinger, B. Leopold, P. Lind, et al., Changes in zinc level of serum, whole blood and red blood cells in thyroid disease, Wiener Klin. Wochenschr.
18, 619–621 (1988).
G. Saner, S. V. Baysal, E. Ünüvar, et al., Serum zinc, copper levels and copper/zinc ratios in infants with sepsis syndrome, J. Trace Elements Exp. Med.
13, 265–270 (2000).
J. Kadrabova, A. Madaric, F. Podvinsky, et al., Plasma zinc, copper and copper/zinc ratio in intrinsic asthma, J. Trace Elements Med. Biol.
10, 50–53 (1996).
P. L. Leung and X. L. Li, Multielement analysis in serum of thyroid cancer patients before and after a surgical operation, Biol. Trace Element Res.
28, 223–226 (1996).
K. Aihara, Y. Nishi, S. Hatano, et al., Zinc, copper, magnase and selenium metabolism in thyroid disease, Am. J. Clin. Nutr.
40, 26–35 (1984).
C. N. Schrauzer, Selenium. Mechanistic aspect of anticarinogenic action, Biol. Trace Element Res.
33, 51–62 (1992).
L. N. Vernie, M. De Vries, C. Benskhuijsen, et al., Selenium levels in blood and plasma and glutathione peroxidase activity in blood of breast cancer patients during adjutant treatment with cyclophosphamide, methotrexate and 5-fluorouracil, Cancer Lett.
18, 283–289 (1983).
J. Aaseth, H. Frey, E. Glatter, et al., Selenium concentration in the human thyroid gland, Biol. Trace Element Res.
24, 147–152 (1990).
D. Behne, A. Kyriakopoulos, C. Weiss-Nowak, et al., Newly found selenium containing proteins in the tissues of the rat, Biol. Trace Element Res.
55, 99–110 (1996).
G. N. Schrauzer, Anticarcinogenesis effects of selenium, Cell. Mol. Life Sci.
57, 1864–1873 (2000).